GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vectus Biosystems Ltd (ASX:VBS) » Definitions » Price-to-Funds-From-Operations

Vectus Biosystems (ASX:VBS) Price-to-Funds-From-Operations : (As of Jul. 26, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Vectus Biosystems Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Vectus Biosystems Business Description

Traded in Other Exchanges
N/A
Address
3-11 Primrose Avenue, Rosebery, Sydney, NSW, AUS, 2018
Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company is in the process of developing a treatment for fibrosis and high blood pressure, which includes heart, kidney, and liver diseases. The company has also developed a technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories.